The Oral Microbiota is Associated With Autoimmune Thyroiditis

NCT03447093 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2018-02-27

No results posted yet for this study

Summary

Autoimmune thyroiditis (AITD) mainly includes Hashimoto's thyroiditis (HT) and Grave's disease (GD). Studies have shown that autoimmune thyroiditis is closely related to microbial disorders such as autoimmune thyroiditis However, there is no report on the relationship between oral microecology and autoimmune thyroiditis. Therefore, our group will study the correlation between oral microbiota and AITD.

Conditions

  • Microbiota

Interventions

DRUG

Methimazole Pill

Patients who developed GD received methimazole treatment

DRUG

Propylthiouracil Pill

Patients who developed GD received propylthiouracil treatment

Sponsors & Collaborators

  • First Affiliated Hospital of Harbin Medical University

    lead OTHER

Principal Investigators

  • Yunwei Wei · First Affiliated Hospital of Harbin Medical University

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-12-23
Primary Completion
2019-12-31
Completion
2021-12-31
FDA Drug
Yes

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03447093 on ClinicalTrials.gov